Deep vein thrombosis (DVT) is serious condition wherein blood

clots occur in deep veins within you body. This condition usually
occurs in your legs. DVT can cause leg pain or swelling but can
also occur without any symptoms.

A German study published by the National Center for

Biotechnology Information in the United States indicates that
the incidence of DVT in SARS-CoV-2 patients has only been
through numbered studies. The study indicates that DVT was
higher in patients positive with SARS-Cov-2. DVT and elevated
D-dimer levels were associated with an increased mortality
rate.

The study recommends the determination of D-dimer levels. D-

dimer is a fibrin degradation product and is present in blood
clots. This test helps diagnose thrombosis. The study
recommends this so that patients suspected or confirmed with
SARS-Cov2 can be recognized early and therapeutic
anticoagulation can be started.

The further study conducted with 20 positive SARS-Cov2

patients. Indicated that 5 in 20 patients were diagnosed with
DVT. Although these patients were in the 60–69-year-old age
group. The DVT rate in the control group was 20%. Despite this
result it is still unclear whether DVT is triggered by SARS-Cov2.
How the virus specifically influences occurrence of DVT and
coagulation cannot be determined. Speculation shows that the
SARS-Cov2 virus could attack the vascular wall directly which
triggers and immunological response thus leading to local
thrombosis to occur due to the initial damage. Another
collective study shows a control group of 184 CoVid-19 patients
that required intensive care which showed a 1% DVT in
patients. Although 14% of said patients were found with
pulmonary artery embolisms which suggest local thrombosis.
In conclusion CoVid-19 infection is associated with an increased
risk of thromboembolic events. The occurrence of DVT was
significantly increased in the study provided by NCBI. DVT and
increased D – Dimer values were also associated with an
increased mortality rate. The study recommends that all
inpatients admitted with SARS-Cov2 undergo D-dimer tests so
that DVT can be detected early on and therapeutic
anticoagulation can be started.